Woodline Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-670,867	Closed	-$4.54M	–	1009
2024 Q4	$4.54M	Sell	670,867 -452	-0.1%	-$3.06K	0.03%	503
2024 Q3	$4.42M	Buy	671,319 +6,869	+1%	+$45.3K	0.04%	399
2024 Q2	$4.98M	Buy	+664,450	New	+$4.98M	0.05%	339